SEC Form 4 · accession 0000891293-15-000070
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jack W Singer
Officer — EVP Global Medical Affairs · Director
Period of report
Dec 18, 2015
Accepted (ET)
Dec 18, 2015 · 4:41 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 18, 2015 | S | 1,904 | $1.17 | D | 1,319,946 | D | |
| Common Stock | Dec 18, 2015 | S | 2,000 | $1.175 | D | 1,317,946 | D | |
| Common Stock | Dec 18, 2015 | S | 10,696 | $1.18 | D | 1,307,250 | D | |
| Common Stock | Dec 18, 2015 | S | 400 | $1.185 | D | 1,306,850 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 trading plan.